TP53 and neoplasm: A similar phenomenon has been reported for genetic reduction of ATR activity limiting the tumour growth of P53-deficient tumours in mice [135], although an increased risk of cancer in some Seckel syndrome patients has been reported, with at least one of these having a causative genetic defect in the ATR gene [136, 137].